Skip to main content
PegBio Co., Ltd. logo

PegBio Co., Ltd. — Investor Relations & Filings

Ticker · 2565 ISIN · CNE100006T44 HKEX Professional, scientific and technical activities
Filings indexed 2,125 across all filing types
Latest filing 2017-07-14 Governance Information
Country HK Hong Kong
Listing HKEX 2565

About PegBio Co., Ltd.

http://www.pegbio.com

PegBio Co., Ltd. is a biotechnology company specializing in the in-house discovery and development of innovative therapies for chronic diseases, primarily focusing on the endocrine and metabolic fields. The company leverages its proprietary HECTORTM technology system to design and screen novel molecular entities, including peptide, protein, and small-molecule drugs, targeting unmet clinical needs. PegBio's robust pipeline addresses major chronic conditions such as Type 2 Diabetes (T2DM), obesity, and metabolic dysfunction-associated steatohepatitis (MASH). Key pipeline assets include long-acting GLP-1 receptor agonists, such as Vepinatide, developed for T2DM treatment and weight management. The company emphasizes creating complementary, multi-benefit product pipelines characterized by new targets, new sites, and new mechanisms of action.

Recent filings

Filing Released Lang Actions
PROPOSED ADOPTION OF NEW BYE-LAWS
Governance Information Classification · 95% confidence The document is an announcement by CMBC Capital Holdings Limited regarding the proposed adoption of new bye-laws to reflect amendments to the Listing Rules and Bermuda laws. It discusses governance-related changes such as board meetings, shareholder meetings, voting procedures, and auditor appointments. The document is an announcement of proposed changes and the intention to send a circular to shareholders for approval at a general meeting. It does not contain actual financial data, detailed financial performance, or full reports. The content focuses on governance structure and rules, specifically amendments to bye-laws, which aligns with Governance Information filings. The document is not a full report but an announcement of proposed governance changes, so it fits best under Governance Information (CGR). The document length (5544 characters) supports it being a detailed announcement rather than a brief notice or a full annual report. Therefore, the classification is CGR with high confidence.
2017-07-14 English
CHANGE OF FINANCIAL YEAR END DATE
Regulatory Filings Classification · 95% confidence The document is an announcement from CMBC Capital Holdings Limited regarding a change in the company's financial year end date. It states the new year end date and explains the reasons for the change, including alignment with its indirect controlling shareholders. The document does not contain any financial statements or detailed financial data, nor does it present a full report. It is a regulatory announcement about a change in reporting periods, made pursuant to listing rules. The document length is relatively short (3468 characters), and it serves as an official notification rather than a full financial report or detailed management discussion. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2017-07-14 English
SUPPLEMENTAL ANNOUNCEMENT
Capital/Financing Update Classification · 95% confidence The document is a short announcement supplementing a previous announcement related to a subscription of notes (a financing activity). It clarifies the names of entities involved in the transaction. The document is only 1577 characters long and does not contain financial statements or detailed financial data. It is not a full report but an update or supplement to a prior announcement about capital raising. Therefore, it fits best under Capital/Financing Update (CAP).
2017-07-13 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 JUNE 2017
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 30/06/2017, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorised share capital, issued share capital, share options, warrants, convertibles, and other share-related activities. The content focuses on changes in share capital and securities movements rather than financial performance, earnings, or management commentary. It is a regulatory filing reporting share capital movements for a specific month, typical of a regulatory compliance report rather than a financial report or announcement of voting results. The document is substantive and detailed, not a brief announcement or certification. Therefore, the best fitting category is Regulatory Filings (RNS), as it is a general regulatory announcement about share capital movements that does not fit into more specific categories like Share Issue/Capital Change (SHA) because it covers a broad range of share capital movements and is a monthly return report to the exchange.
2017-07-04 English
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
Board/Management Information Classification · 95% confidence The document provides an updated list of directors and their roles and functions on the Board of Directors of CMBC Capital Holdings Limited. It includes details about executive, non-executive, and independent non-executive directors, as well as their membership in various board committees. There is no financial data, no mention of financial results, no regulatory filings, no voting results, or any other report type. The content is clearly about board/management information, specifically changes or updates to the board composition and committee memberships. Therefore, the document fits best under the category 'Board/Management Information' (MANG). The document length is short and focused solely on board information, reinforcing this classification. Confidence is high due to the clear and direct nature of the content.
2017-06-28 English
RESIGNATION OF DIRECTORS AND CHANGE IN COMPOSITION OF BOARD COMMITTEES
Board/Management Information Classification · 100% confidence The document is an announcement regarding the resignation of several directors and changes in the composition of board committees following a change in control of the company. It specifically lists the resignations of executive and independent non-executive directors and mentions the new board composition. There is no financial data, no report attached or referenced, and no mention of shareholder voting results or other types of filings. The content clearly fits the category of announcements about changes in the company's board of directors or senior management. Therefore, the appropriate classification is Board/Management Information (MANG). The document length is short and it is not a report publication announcement or regulatory filing. Confidence is high due to clear and direct content about board changes.
2017-06-28 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.